is a Managing Director in Cambridge, MA, USA.
Prior to joining Novartis Venture Fund, he worked at the Novartis Institutes for BioMedical Research as the Director of Special Projects. Campbell is a New Zealand-trained physician and worked as a Medical House Officer at Auckland Hospital. He is a Kauffman Fellow and holds an MBA from Harvard Business School and an MPP (public policy) from the John F. Kennedy School of Government, where he was a Knox Fellow and Rotary Ambassadorial Scholar.
Exits: Akebia Therapeutics, Inc. (NASDAQ: AKBA)
Aerpio Therapeutics, Inc. (Board Seat)
Alios BioPharma Inc. (Board Seat)
Euthymics Bioscience, Inc. (Board Seat)
Galera Therapeutics, Inc. (Board Seat)
ImaginAB, Inc. (Board Seat)
Neurovance, Inc. (Board Seat)
Tokai Pharmaceuticals, Inc. (Board Seat)